SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
Benzinga
DECEMBER 21, 2023
The Merger is exactly that: a more attractive alternative that retains our stockholders' exposure to our highly attractive technology and future potential through a continuing majority interest, while also creating new opportunities for value creation. The capital structure of the combined company is not risky.
Let's personalize your content